Analytical Data
-
Gene name
DCAKD
- Application
-
Alternative Names
DCAKDDephospho-CoA kinase domain-containing protein
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8WVC6
-
Expression Region
1-231aa
-
AA Sequence
MFLVGLTGGIASGKSSVIQVFQQLGCAVIDVDVMARHVVQPGYPAHRRIVEVFGTEVLLENGDINRKVLGDLIFNQPDRRQLLIAITHPEIRKEMMKETFKYFLRGYRYVILDIPLLFETKKLLKYMKHTVVVYCDRDTQLARLMRRNSLNRKDAEARINAQLPLTDKARMARHVLDNSGEWSVTKRQVILLHTELERSLEYLPLRFGVLTGLAAIASLLYLLTHYLLPYA
-
Molecular Weight
52.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DCAKD is a newly identified recombinant protein that has garnered attention in the fields of molecular biology and biotechnology due to its potential therapeutic applications. The protein is derived from a unique fusion of domains found in existing proteins, which have been shown to play a role in cellular signaling and metabolic regulation. Research has indicated that DCAKD may be involved in critical biological processes such as cell proliferation, differentiation, and apoptosis, making it a target of interest for understanding various diseases, including cancer and metabolic disorders. The recombinant expression of DCAKD in host systems allows for detailed analysis of its biochemical properties and functional mechanisms. Studies utilizing techniques such as site-directed mutagenesis and protein crystallization are underway to elucidate the structure-function relationship of DCAKD. By understanding how this protein interacts with cellular pathways and its role in disease progression, researchers hope to uncover new therapeutic strategies, potentially leading to the development of novel drugs or treatment protocols. The ongoing exploration of DCAKD represents a promising frontier in the quest to harness protein engineering for medical advancements, highlighting the significance of fundamental research in uncovering the complexities of protein interactions and their implications for human health.
